Filter by:
Set up in 1999, as a part of the implementation of the three-years plan for the fight against drugs and to prevent dependence, SINTES (the national poison/substance identification system) has made up for the lack of data on synthetic drugs consumed in France.
Although an essential indicator of public health, mortality due to illicit drugs is not well documented in France.
In the 2000s, a new method was developed for estimating psychoactive substance use: testing drug residues in sewage. Ten or so years later, this innovative method, sewage epidemiology, is now applied in numerous countries.
This document, produced in collaboration with the Regional Health Observatories of Martinique, French Guiana and Réunion, presents the results of the EnCLASS 2021 survey in these three territories.
Since 2007, OFDT has been publishing Drugs, Key Data, an overall perspective digest with the most recent and detailed facts and figures.
Levels of use of alcohol, tobacco and psychotropic drugs do not come within the same context and do not even have the same history. However these three substances have at least two points in common: their use is legal and they are the only psychoactive products still used beyond the age of 60 years.
The profile and practices of drug users from the national users survey of the harm reduction facilities, Reception and Harm Reduction Support Centres (CAARUD).
This issue of Tendances examines law enforcement on driving under the influence of alcohol or other drugs, reviewing the most recent trends in road traffic controls and driving under the influence enforcement, as well as the criminal justice system response to these specific alcohol and drug issues.
Precursor trafficking draws little attention as efforts are focused on seizures of finished products listed as narcotics. Yet, this trafficking is a reality that now touches all continents and makes use of all major global trade routes.
In Europe, France and the Netherlands both stand for opposite models of drug policies as far as public opinion is concerned.
Forty years after the passing of the original 31 December 1970 law prohibiting drug use, this issue of Tendances analyses the trends in arrests for narcotics use and the subsequent sentences handed down by the French legal system.
Monitoring drug-using patients in general medicine: qualitative approach. Psychotropic drugs and dependence: users profiles and behaviour patterns.
Based on a research work coordinated by the OFDT, this issue of Tendances shows that cannabis regulation raised both traditional drug policy implementation challenges and unique challenges.
The use of illicit psychotropic drugs by people integrated into a business environment constitutes a very recent field of research in France.
This issue of Tendances focuses on the key results of the fourteenth annual TREND scheme (Emerging Trends and New Drugs) and the scheme's seven sites.
The ARAMIS study (Attitudes, perceptions, aspirations and motives surrounding the introduction to psychoactive substances) aims to explore the perceptions and motives for drug use among minors, and their trajectories for alcohol, tobacco, cannabis and/or other illicit drug use.
Since the end of the 1990s, poverty, precariousness, exclusion, integration or reintegration have been at the heart of all the social debates.
This summary sets out the observations from the second year of operation of the TREND scheme (Recent trends and new drugs).
In France, the levels of legal and illegal drug use in adolescence, as well as recent trends in such use, have been assessed over the last fifteen years or so through a group of representative surveys of the general population.
The third edition (1999, 2002, 2008) of the Survey on Representations, Opinions, and Perceptions Regarding Psychoactive Drugs (EROPP) provided information about representations, opinions and perceptions French people have with regard to psychoactive substances and helped review changes in the French population's understanding and opinions related to drugs and the main public policies developed…
